ms and glp 1 Your GLP-1 Game Plan GLP-1s and Multiple Sclerosis -

But not all telehealth companies are adequately evaluating patients before writing prescriptions, said Marc-Andre Cornier, an endocrinologist at the Medical University of South Carolina and the immediate past president of The Obesity Society

The National Institute for Health and Care Excellence (NICE) recommends GLP-1 receptor agonists for adults with type 2 diabetes when metformin and other oral therapies have not achieved adequate glycaemic control

Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials To view or add a comment, sign in More Relevant Posts The upheaval of the Health and Human Services workforce and leadership leaves much to be desired in terms of delivery, recently retired FDA Chief Information Officer Vid Desai tells BioSpace, but the regulatory agency is evolving to be more open to much needed change

But what surprises everyone is how many benefits are weight independent, said Dr

This article is not medical advice